Biorasis Inc. logo

Biorasis Inc.

Pioneering real-time, wireless sensor technology for continuous glucose and bio-analyte monitoring to enhance healthcare across various medical conditions.

VS
Glycobond logo

Glycobond

The company’s first product is an assay for HCC diagnosis, HepaCheC®

Side-by-Side Comparison

Metric Biorasis Inc. Glycobond
Founded 2007 2011
Headquarters Mansfield, United States Linkoping, Sweden
Employees 9 1
Industry Biotechnology, Health Care, IT Biotechnology, Health Care
Funding Stage Unknown Grant
Total Funding $3.59M $50.00K
Funding Rounds 3 3
Business Model Not tracked yet Not tracked yet
Revenue Model Not tracked yet Not tracked yet
Services Not tracked yet Not tracked yet
Target Customers Not tracked yet Not tracked yet
Taxonomy Real-time Monitoring, Wireless Sensor Technology, Continuous Glucose Monitoring, Bio-analyte Monitoring, Miniaturized Sensor Platform, Cardiovascular Diagnostics, Cancer Diagnostics, Liver Function Monitoring, Kidney Function Monitoring, Stroke Monitoring, Epilepsy Monitoring, Implantable Sensors, UCONN Collaboration, OSCI Technology Medical Diagnostics, Cancer Diagnosis, Liver Diseases, Carbohydrate-binding Peptides, Recombinant Technology, CE-marked Assay, HCC Diagnosis, Liver Cancer Monitoring
Website bio-orasis.com glycobond.com
Biorasis Inc. logo

About Biorasis Inc.

Biorasis Inc., founded in December 2007, is at the forefront of developing cutting-edge, real-time, wireless sensor technology designed for continuous glucose and bio-analyte monitoring. With its origins in research at UCONN and OSCI, the company has developed a miniaturized sensor platform that is...

Glycobond logo

About Glycobond

Glycobond is a biotechnology startup based in Sweden that utilizes recombinant technology to produce carbohydrate-binding peptides for the diagnosis and monitoring of liver diseases and cancer. Their flagship product, HepaCheC®, is a CE-marked assay designed to aid in the diagnosis of primary liver...

Frequently Asked Questions

Biorasis Inc. — Pioneering real-time, wireless sensor technology for continuous glucose and bio-analyte monitoring to enhance healthcare across various medical conditions.. Glycobond — The company’s first product is an assay for HCC diagnosis, HepaCheC®. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Biorasis Inc. has raised $3.59M while Glycobond has raised $50.00K.
Biorasis Inc. and Glycobond operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors Biorasis Inc., Glycobond, and millions of companies for 40+ signal types.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy